Clinical ResearchPost-Infarction Myocardial Perfusion ImagingAn Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction
Post-Infarction Myocardial Perfusion Imaging
Under an Elsevier user license
open archive
Abbreviations and Acronyms
ADSPECT
adenosine technetium-99m sestamibi single-photon emission computed tomography
AMI
acute myocardial infarction
BB
beta-blockers
CABG
coronary artery bypass grafting
CAD
coronary artery disease
CCB
calcium-channel blocker
EF
ejection fraction
LAD
left anterior descending
LV
left ventricular
PCI
percutaneous coronary intervention
PDS
perfusion defect size
Cited by (0)
Funding for INSPIRE was provided by Bristol-Myers Squibb Medical Imaging, Astellas Pharma US, and the Schering Plough Research Institute.
- 1
Dr. Mahmarian is on the Advisory Board for CV Therapeutics and Astellas Pharma US.
- 2
Dr. Shaw has received research grants for the END and COURAGE trials
- 3
Dr. Filipchuk received research grants for the DIAD, CCORD, and AMISCAN studies
- 4
Drs. Iskander and Henzlova are on the Speakers’ Bureau for Bristol-Myers Squibb.
Copyright © 2006 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.